Collaborations, FDA Approvals, Appointments, Patents, and Stock Movements - Research Report on Aetna, United Therapeutics, Perrigo, Arena Pharmaceuticals, and Keryx Biopharmaceuticals
ownload free of charge at:
United Therapeutics Corporation Research Report
On December 20, 2013, United Therapeutics Corporation (United Therapeutics) announced that its Orenitram (treprostinil) Extended-Release Tablets have been approved by the United States Food and Drug Administration (FDA) for the treatment of pulmonary arterial hypertension (PAH) in WHO Group I patients to improve exercise capacity. Commenting on the approval, Roger Jeffs, Ph.D., President and Chief Operating Officer of United Therapeutics stated, "This approval marks the first time that the FDA has approved an orally administered prostacyclin analogue for any disease - and our fifth approval from the FDA for treatment of PAH - supporting our mission of providing a wider choice of PAH therapies for physicians and patients. We are grateful for the FDA's thorough review and will continue to build clinical support for the use of Orenitram." The Full Research Report on United Therapeutics Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Perrigo Co. Research Report
On December 18, 2013, Perrigo Co. (Perrigo) announced that the Company has appointed Board of Directors, effective until its annual general meeting on November 2014. The Company informed that Joseph C. Papa, President and CEO of the Company, has been named Chairman of the Board, and Gary K. Kunkle, Jr., has been named Lead Independent Director. Perrigo added that Mr. Papa will head an 11-member Board that will include all of the former membePage: 1 2 3 4 5 Related biology technology :1
. New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline2
. California Biomedical Companies Report Higher Product Approvals, Fewer Delays3
. The 2013 CES: Patents, Legislation Reform, and the Growing Market for Patent Attorneys and Agents Reviewed by Wysebridge4
. Synthetic Biologics Announces Proposed Public Offering of Common Stock5
. MiMedx Group Announces Proposed Public Offering of Common Stock6
. Soligenix Announces Initial $600,000 Investment and up to $10.6 Million Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC7
. Northwest Biotherapeutics Announces Pricing Of Public Offering Of Common Stock And Warrants8
. Z Trim Holdings, Inc. Announces Pricing of Public Offering of Common Stock and Warrants9
. DURECT Announces Pricing of Public Offering of Common Stock10
. InterMune Announces Pricing of Public Offering of 6,500,000 Shares of Common Stock11
. Discovery Labs Prices $50 Million Public Offering of Common Stock
(Date:1/15/2014)... IPSWICH, England , January 15, 2014 ... whether technology developed to win races on the Formula ... obesity. This unique healthcare collaboration between McLaren Applied Technologies ... academics at University Campus Suffolk is being funded by ... inspired by equipment used to collect data about the ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how ... these latent viruses is the Epstein Barr Virus (EBV), ... Rheumatoid arthritis (RA) is a chronic inflammatory disease that ... a study found that RA patients have high concentrations ... What is Microcompetition? , Dr. Hanan Polansky discovered that ...
(Date:1/15/2014)... 15, 2014 Freeslate, Inc ... solutions, today announced that Lupin Limited, one of ... of Freeslate’s CM Protégé PharmD System ... Lupin, headquartered in Mumbai, India, is focused on ... branded formulations and Active Pharmaceutical Ingredients (APIs) for ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ... Breaking Biology Technology:Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN ... and Alkermes, Inc. (Nasdaq: ALKS ) today announced ... has been accepted for review by the U.S. Food and ... an investigational sustained release medication for type 2 diabetes that ...
... DETROIT, July 7 Caraco Pharmaceutical Laboratories, Ltd. (NYSE ... on behalf of Sun Pharmaceutical Industries Ltd. (Sun Pharma), ... US Food and Drug Administration (FDA) for its Abbreviated ... , Bicalutamide tablets are an androgen receptor inhibitor ...
... July 7 The following letter is being released by CEL-SCI Corporation ... , Dear Fellow Shareholders: , , Recently we have been hearing ... You may think to yourself, this is no big deal since it does ... disappeared. Wrong - on both counts! In this letter I will ...Cached Biology Technology:New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 2New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 3New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 4New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 5New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 6Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets 2CEL-SCI Corporation Releases Letter to Shareholders 2CEL-SCI Corporation Releases Letter to Shareholders 3CEL-SCI Corporation Releases Letter to Shareholders 4CEL-SCI Corporation Releases Letter to Shareholders 5CEL-SCI Corporation Releases Letter to Shareholders 6CEL-SCI Corporation Releases Letter to Shareholders 7
(Date:3/11/2014)... EU, while energy-saving lamps remain a bone of contention. In ... 10 watts as well. LEDs (light-emitting diodes) therefore have the ... Experts reckon that LED retrofit lamps for use in standard ... time from 2015. By 2020 it is predicted that LEDs ... lighting market. The tiny diodes offer a whole host of ...
(Date:3/10/2014)... findings were reported by scientists from the German Leibniz ... study published in the British Ecological Society,s ... to show that seed-dispersing bats avoid feeding in light-polluted ... bats ( Carollia sowelli ), Daniel Lewanzik from the ... a flight cage into two compartments. One was naturally ...
(Date:3/10/2014)... graduate students from institutes throughout North America have ... Weintraub Graduate Student Award sponsored by the Basic ... Nominations were solicited internationally; the winners were selected ... significance of their work. , The recipients, all ... their studies in the biological sciences, will participate ... Breaking Biology News(10 mins):LED lamps: Less energy, more light 2LED lamps: Less energy, more light 3Light pollution impairs rainforest regeneration 22014 Harold M. Weintraub Graduate Student Award winners announced 2
... Testing Laboratory (RTL) can provide you ... years. ,,Microbial method development and validation ... the conditions of your GMP manufacturing ... products,,We offer a full spectrum of ...
... QED Bioscience has over 23 years of ... lines. We have made antibodies to large ... and viral antigens, and plasmid DNA-encoded antigens. ... is unique, so our hybridoma development programs ...
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
... Rapid-Screen cDNA Library Panels were designed for ... sets of PCRs to identify the desired ... performed in a 96-well "Master Plate," where ... clones. Having identified the positive well(s) by ...Biology Products: